1 Introduction to Research & Analysis Reports
    1.1 Adoptive Cellular Immunotherapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Adoptive Cellular Immunotherapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Adoptive Cellular Immunotherapy Overall Market Size
    2.1 Global Adoptive Cellular Immunotherapy Market Size: 2021 VS 2028
    2.2 Global Adoptive Cellular Immunotherapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Adoptive Cellular Immunotherapy Players in Global Market
    3.2 Top Global Adoptive Cellular Immunotherapy Companies Ranked by Revenue
    3.3 Global Adoptive Cellular Immunotherapy Revenue by Companies
    3.4 Top 3 and Top 5 Adoptive Cellular Immunotherapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Adoptive Cellular Immunotherapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Adoptive Cellular Immunotherapy Players in Global Market
        3.6.1 List of Global Tier 1 Adoptive Cellular Immunotherapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Adoptive Cellular Immunotherapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Adoptive Cellular Immunotherapy Market Size Markets, 2021 & 2028
        4.1.2 TIL
        4.1.3 LAK
        4.1.4 CAR-T
        4.1.5 TCR-T
        4.1.6 CIK
        4.1.7 NK
        4.1.8 DC
        4.1.9 Other
    4.2 By Type - Global Adoptive Cellular Immunotherapy Revenue & Forecasts
        4.2.1 By Type - Global Adoptive Cellular Immunotherapy Revenue, 2017-2022
        4.2.2 By Type - Global Adoptive Cellular Immunotherapy Revenue, 2023-2028
        4.2.3 By Type - Global Adoptive Cellular Immunotherapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Adoptive Cellular Immunotherapy Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Cancer Hospital
        5.1.4 Centers for Disease Control and Prevention
        5.1.5 Rehabilitation Center
        5.1.6 Other
    5.2 By Application - Global Adoptive Cellular Immunotherapy Revenue & Forecasts
        5.2.1 By Application - Global Adoptive Cellular Immunotherapy Revenue, 2017-2022
        5.2.2 By Application - Global Adoptive Cellular Immunotherapy Revenue, 2023-2028
        5.2.3 By Application - Global Adoptive Cellular Immunotherapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Adoptive Cellular Immunotherapy Market Size, 2021 & 2028
    6.2 By Region - Global Adoptive Cellular Immunotherapy Revenue & Forecasts
        6.2.1 By Region - Global Adoptive Cellular Immunotherapy Revenue, 2017-2022
        6.2.2 By Region - Global Adoptive Cellular Immunotherapy Revenue, 2023-2028
        6.2.3 By Region - Global Adoptive Cellular Immunotherapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Adoptive Cellular Immunotherapy Revenue, 2017-2028
        6.3.2 US Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.3.3 Canada Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.3.4 Mexico Adoptive Cellular Immunotherapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Adoptive Cellular Immunotherapy Revenue, 2017-2028
        6.4.2 Germany Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.4.3 France Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.4.4 U.K. Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.4.5 Italy Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.4.6 Russia Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.4.7 Nordic Countries Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.4.8 Benelux Adoptive Cellular Immunotherapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Adoptive Cellular Immunotherapy Revenue, 2017-2028
        6.5.2 China Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.5.3 Japan Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.5.4 South Korea Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.5.5 Southeast Asia Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.5.6 India Adoptive Cellular Immunotherapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Adoptive Cellular Immunotherapy Revenue, 2017-2028
        6.6.2 Brazil Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.6.3 Argentina Adoptive Cellular Immunotherapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Adoptive Cellular Immunotherapy Revenue, 2017-2028
        6.7.2 Turkey Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.7.3 Israel Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Adoptive Cellular Immunotherapy Market Size, 2017-2028
        6.7.5 UAE Adoptive Cellular Immunotherapy Market Size, 2017-2028
7 Players Profiles
    7.1 Amgen Inc
        7.1.1 Amgen Inc Corporate Summary
        7.1.2 Amgen Inc Business Overview
        7.1.3 Amgen Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.1.4 Amgen Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.1.5 Amgen Inc Key News
    7.2 Autolus Therapeutics Plc
        7.2.1 Autolus Therapeutics Plc Corporate Summary
        7.2.2 Autolus Therapeutics Plc Business Overview
        7.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Major Product Offerings
        7.2.4 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.2.5 Autolus Therapeutics Plc Key News
    7.3 Beijing Immunochina Medical Science & Technology Co Ltd
        7.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Corporate Summary
        7.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
        7.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Key News
    7.4 Bellicum Pharmaceuticals Inc
        7.4.1 Bellicum Pharmaceuticals Inc Corporate Summary
        7.4.2 Bellicum Pharmaceuticals Inc Business Overview
        7.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.4.4 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.4.5 Bellicum Pharmaceuticals Inc Key News
    7.5 Bristol-Myers Squibb Co
        7.5.1 Bristol-Myers Squibb Co Corporate Summary
        7.5.2 Bristol-Myers Squibb Co Business Overview
        7.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Major Product Offerings
        7.5.4 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.5.5 Bristol-Myers Squibb Co Key News
    7.6 bluebird bio Inc
        7.6.1 bluebird bio Inc Corporate Summary
        7.6.2 bluebird bio Inc Business Overview
        7.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.6.4 bluebird bio Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.6.5 bluebird bio Inc Key News
    7.7 CARsgen Therapeutics Ltd
        7.7.1 CARsgen Therapeutics Ltd Corporate Summary
        7.7.2 CARsgen Therapeutics Ltd Business Overview
        7.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.7.4 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.7.5 CARsgen Therapeutics Ltd Key News
    7.8 Celgene Corp
        7.8.1 Celgene Corp Corporate Summary
        7.8.2 Celgene Corp Business Overview
        7.8.3 Celgene Corp Adoptive Cellular Immunotherapy Major Product Offerings
        7.8.4 Celgene Corp Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.8.5 Celgene Corp Key News
    7.9 Cell Medica Ltd
        7.9.1 Cell Medica Ltd Corporate Summary
        7.9.2 Cell Medica Ltd Business Overview
        7.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.9.4 Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.9.5 Cell Medica Ltd Key News
    7.10 Cellular Biomedicine Group Inc
        7.10.1 Cellular Biomedicine Group Inc Corporate Summary
        7.10.2 Cellular Biomedicine Group Inc Business Overview
        7.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.10.4 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.10.5 Cellular Biomedicine Group Inc Key News
    7.11 Celularity Inc
        7.11.1 Celularity Inc Corporate Summary
        7.11.2 Celularity Inc Business Overview
        7.11.3 Celularity Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.11.4 Celularity Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.11.5 Celularity Inc Key News
    7.12 Celyad SA
        7.12.1 Celyad SA Corporate Summary
        7.12.2 Celyad SA Business Overview
        7.12.3 Celyad SA Adoptive Cellular Immunotherapy Major Product Offerings
        7.12.4 Celyad SA Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.12.5 Celyad SA Key News
    7.13 Daiichi Sankyo Co Ltd
        7.13.1 Daiichi Sankyo Co Ltd Corporate Summary
        7.13.2 Daiichi Sankyo Co Ltd Business Overview
        7.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.13.4 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.13.5 Daiichi Sankyo Co Ltd Key News
    7.14 Fosun Pharmaceutical AG
        7.14.1 Fosun Pharmaceutical AG Corporate Summary
        7.14.2 Fosun Pharmaceutical AG Business Overview
        7.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Major Product Offerings
        7.14.4 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.14.5 Fosun Pharmaceutical AG Key News
    7.15 Gilead Sciences Inc
        7.15.1 Gilead Sciences Inc Corporate Summary
        7.15.2 Gilead Sciences Inc Business Overview
        7.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.15.4 Gilead Sciences Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.15.5 Gilead Sciences Inc Key News
    7.16 Guangzhou Anjie Biomedical Technology Co Ltd
        7.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Corporate Summary
        7.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
        7.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Key News
    7.17 Hangzhou Converd Co Ltd
        7.17.1 Hangzhou Converd Co Ltd Corporate Summary
        7.17.2 Hangzhou Converd Co Ltd Business Overview
        7.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.17.4 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.17.5 Hangzhou Converd Co Ltd Key News
    7.18 Hebei Senlang Biotechnology Inc Ltd
        7.18.1 Hebei Senlang Biotechnology Inc Ltd Corporate Summary
        7.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
        7.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.18.4 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.18.5 Hebei Senlang Biotechnology Inc Ltd Key News
    7.19 HRAIN Biotechnology Co Ltd
        7.19.1 HRAIN Biotechnology Co Ltd Corporate Summary
        7.19.2 HRAIN Biotechnology Co Ltd Business Overview
        7.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.19.4 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.19.5 HRAIN Biotechnology Co Ltd Key News
    7.20 Juno Therapeutics Inc
        7.20.1 Juno Therapeutics Inc Corporate Summary
        7.20.2 Juno Therapeutics Inc Business Overview
        7.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.20.4 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.20.5 Juno Therapeutics Inc Key News
    7.21 Kite Pharma Inc
        7.21.1 Kite Pharma Inc Corporate Summary
        7.21.2 Kite Pharma Inc Business Overview
        7.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.21.4 Kite Pharma Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.21.5 Kite Pharma Inc Key News
    7.22 Nanjing Legend Biotech Co Ltd
        7.22.1 Nanjing Legend Biotech Co Ltd Corporate Summary
        7.22.2 Nanjing Legend Biotech Co Ltd Business Overview
        7.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.22.4 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.22.5 Nanjing Legend Biotech Co Ltd Key News
    7.23 NantKwest Inc
        7.23.1 NantKwest Inc Corporate Summary
        7.23.2 NantKwest Inc Business Overview
        7.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.23.4 NantKwest Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.23.5 NantKwest Inc Key News
    7.24 Nkarta Inc
        7.24.1 Nkarta Inc Corporate Summary
        7.24.2 Nkarta Inc Business Overview
        7.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.24.4 Nkarta Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.24.5 Nkarta Inc Key News
    7.25 Novartis AG
        7.25.1 Novartis AG Corporate Summary
        7.25.2 Novartis AG Business Overview
        7.25.3 Novartis AG Adoptive Cellular Immunotherapy Major Product Offerings
        7.25.4 Novartis AG Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.25.5 Novartis AG Key News
    7.26 Ono Pharmaceutical Co Ltd
        7.26.1 Ono Pharmaceutical Co Ltd Corporate Summary
        7.26.2 Ono Pharmaceutical Co Ltd Business Overview
        7.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.26.4 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.26.5 Ono Pharmaceutical Co Ltd Key News
    7.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
        7.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Corporate Summary
        7.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
        7.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Major Product Offerings
        7.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Key News
    7.28 Sorrento Therapeutics Inc
        7.28.1 Sorrento Therapeutics Inc Corporate Summary
        7.28.2 Sorrento Therapeutics Inc Business Overview
        7.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.28.4 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.28.5 Sorrento Therapeutics Inc Key News
    7.29 Takara Bio Inc
        7.29.1 Takara Bio Inc Corporate Summary
        7.29.2 Takara Bio Inc Business Overview
        7.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Major Product Offerings
        7.29.4 Takara Bio Inc Adoptive Cellular Immunotherapy Revenue in Global Market (2017-2022)
        7.29.5 Takara Bio Inc Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer